Loading SNPS detail
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits.
The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas.
The company was incorporated in 1986 and is headquartered in Mountain View, California.
Chart data unavailable

Synopsys (SNPS) closed at $404.94 in the latest trading session, marking a -1.27% move from the prior day.

CCLA Investment Management trimmed its position in shares of Synopsys, Inc. (NASDAQ: SNPS) by 13.6% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 278,486 shares of the semiconductor company's stock after selling 43,944 shares during the

Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.

SeaTown Holdings Pte. Ltd. grew its holdings in Synopsys, Inc. (NASDAQ: SNPS) by 55.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,300 shares of the semiconductor company's stock after acquiring an additional 8,000 shares during the quarter. Synopsys accounts

Synopsys (NASDAQ: SNPS - Get Free Report) and OptimizeRx (NASDAQ: OPRX - Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Institutional and Insider Ownership 85.5% of Synopsys shares

SNPS' Design IP business faces near-term pressure, but strong AI-driven design wins and rising demand signal a potential rebound in fiscal 2026.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Top insights from the latest market news from Tuesday, March 31, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.

Synopsys remains a buy, offering a rare combination of secular growth, pricing power, and a discounted valuation after recent underperformance. SNPS is wrongly lumped with SaaS peers; its deeply integrated EDA business and non-seat-based pricing model insulate it from AI-driven software disruption. Elliott Investment Management's multibillion-dollar stake introduces a credible catalyst for operational improvements and a re-rating toward historical valuation norms.

Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock?

Synopsys (NASDAQ: SNPS - Get Free Report) and Smith Micro Software (NASDAQ: SMSI - Get Free Report) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Analyst Ratings This is a breakdown

Czech National Bank grew its holdings in Synopsys, Inc. (NASDAQ: SNPS) by 4.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 48,979 shares of the semiconductor company's stock after acquiring an additional 1,981 shares during the quarter. Czech National

Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Congress Asset Management Co. cut its position in Synopsys, Inc. (NASDAQ: SNPS) by 3.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 261,728 shares of the semiconductor company's stock after selling 8,284 shares during the quarter. Congress Asset

Capital Asset Advisory Services LLC lifted its position in shares of Synopsys, Inc. (NASDAQ: SNPS) by 39.2% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 4,606 shares of the semiconductor company's stock after acquiring an additional 1,297 shares during the quarter. Capital Asset Advisory